Global Market for Hospital Infection Therapeutics to Register 3.10% CAGR from 2014 to 2020 due to Increasing Number of Pipeline Drug Molecules A new market research study, titled “Hospital Infection Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,� has been published by Transparency Market Research, providing a comprehensive analysis of the market. The major driving factors, barriers, and current trends of the global hospital infection therapeutics market have been included in the scope of the research report. The global hospital infection therapeutics market was valued at US$3.06 billion in 2013. It is expected to expand at a CAGR of 3.1% between 2014 and 2020, gradually attaining a total market value of US$3.62 billion by 2020.
Hospital-acquired infections are majorly caused by fungal, bacterial, and viral pathogens. Several cases of hospital infections are acquired from the intensive care units of hospitals. A huge number of antimicrobial drugs have demonstrated their capability in treating a wide range of hospital infections. The increasing number of pipeline drug molecules in the hospital infection therapeutics market is one of the biggest opportunities for the growth of the market. In addition, the absence of skilled staff in developing and underdeveloped countries and growing prevalence of several hospitals